清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Impact of Symblepharon Management With Ocular Surface Reconstruction on Scleral Lens Fitting in Eyes With Chronic Cicatrizing Conjunctivitis and Keratopathy

睑球粘连 医学 眼科 视力 外科 角膜
作者
Simmy Chaudhary,Anahita Kate,Sayan Basu,Swapna S. Shanbhag
出处
期刊:Cornea [Ovid Technologies (Wolters Kluwer)]
卷期号:43 (8): 975-981 被引量:4
标识
DOI:10.1097/ico.0000000000003437
摘要

Purpose: The aim of this study was to describe the importance of symblepharon release with ocular surface reconstruction (OSR) for optimal fitting of scleral contact lenses (SCLs) in eyes with chronic cicatrizing conjunctivitis (CCC) and keratopathy. Methods: This retrospective study included 32 eyes with CCC and keratopathy with symblepharon which underwent symblepharon release with OSR and were fitted with SCLs. The primary outcome measure was the improvement in best-corrected visual acuity with SCL wear. Results: A total of 32 eyes of 29 patients (66% men) with a median age of 30.5 years were included. The common causes of CCC were Stevens–Johnson syndrome (66%) and ocular burns (16%). The most common location of symblepharon was superior (59%) with limbal involvement in most eyes (94%). Symblepharon release was combined with mucous membrane grafting (63%), amniotic membrane grafting (31%), or conjunctival autografting (6%). The median interval between symblepharon release with OSR and SCL trial was 15 weeks [interquartile range (IQR): 6–24]. The median best-corrected visual acuity improved from logMAR 1.5 (IQR: 1.2–1.8) to logMAR 1.2 (IQR: 0.6–1.4) with SCLs after symblepharon release with OSR ( P < 0.001). The median diameter of the SCL used was 15 mm (IQR: 15–16), with a median base curve of 7.9 mm (IQR: 7.9–8). Symblepharon recurrence was noted in 70% of eyes that underwent amniotic membrane grafting; no recurrence was seen with mucous membrane grafting or conjunctival autografting. Conclusions: In eyes with CCC with keratopathy and symblepharon, visual rehabilitation is possible with SCLs after symblepharon release with OSR without having to resort to a penetrating corneal procedure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zct完成签到,获得积分10
3秒前
zh完成签到,获得积分10
4秒前
852应助科研通管家采纳,获得10
13秒前
16秒前
尤里有气发布了新的文献求助10
20秒前
29秒前
叶千山完成签到 ,获得积分10
31秒前
Yvonne发布了新的文献求助10
32秒前
华仔应助Yvonne采纳,获得10
43秒前
晨曦完成签到 ,获得积分10
44秒前
kean1943完成签到,获得积分10
1分钟前
1分钟前
尤里有气发布了新的文献求助10
1分钟前
orixero应助宁羽采纳,获得10
1分钟前
1分钟前
宁羽1完成签到,获得积分10
1分钟前
活泼雪碧发布了新的文献求助10
1分钟前
1分钟前
宁羽完成签到,获得积分10
1分钟前
Yvonne发布了新的文献求助10
1分钟前
2分钟前
BowieHuang应助科研通管家采纳,获得10
2分钟前
激动的似狮完成签到,获得积分10
2分钟前
2分钟前
尤里有气发布了新的文献求助10
2分钟前
RC发布了新的文献求助10
2分钟前
tt完成签到,获得积分10
3分钟前
玛卡巴卡爱吃饭完成签到 ,获得积分10
3分钟前
BowieHuang应助科研通管家采纳,获得10
4分钟前
4分钟前
MTF完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
赘婿应助moonsea0415采纳,获得10
5分钟前
任性的紫翠完成签到,获得积分10
5分钟前
活泼雪碧完成签到 ,获得积分10
5分钟前
5分钟前
moonsea0415发布了新的文献求助10
5分钟前
moonsea0415完成签到,获得积分10
6分钟前
Joins_Su完成签到 ,获得积分10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
King Tyrant 720
T/CIET 1631—2025《构网型柔性直流输电技术应用指南》 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5590568
求助须知:如何正确求助?哪些是违规求助? 4674818
关于积分的说明 14795392
捐赠科研通 4633472
什么是DOI,文献DOI怎么找? 2532825
邀请新用户注册赠送积分活动 1501328
关于科研通互助平台的介绍 1468723